Fixing the injustice of high drug prices: The Tipline for 31 January 2018
This morning’s keenly anticipated state of antitrust news covers pharma litigation in the First Circuit and a bid for class certification in Northern California, plus a preview of a GCR Live Miami panel on efficiencies.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10